The melanin-concentrating hormone (MCH) system in an animal model of depression-like behavior

European Neuropsychopharmacology

Volumn 22, Issue 8, 2012, Pages 607-613

  Garcia Fuster M J ^a   Parks, G S ^a   Clinton, S M ^b   Watson, S J ^b   Akil, H ^b   Civelli, O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Animal model; Depression; MCH; Neuropeptide

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTERONE; MELANIN CONCENTRATING HORMONE; MELANIN CONCENTRATING HORMONE RECEPTOR 1 ANTAGONIST; MESSENGER RNA; NEUROPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; EMOTION; GENETIC DIFFERENCE; HEREDITY; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; CA1 REGION, HIPPOCAMPAL; DEPRESSION; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HYPOTHALAMIC HORMONES; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; MELANINS; NERVE TISSUE PROTEINS; NEURONS; ORGAN SPECIFICITY; PITUITARY HORMONES; RATS; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

EID: 84864531994     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2011.12.001     Document Type: Article

References (27)

1. Bittencourt J.C., Presse F., Arias C., Peto C., Vaughan J., Nahon J.L., Vale W., Sawchenko P.E. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J. Comp. Neurol. 1992, 319:218-245.
2. Borowsky B., Durkin M.M., Ogozalek K., Marzabadi M.R., DeLeon J., Lagu B., Heurich R., Lichtblau H., Shaposhnik Z., Daniewska I., Blackburn T.P., Branchek T.A., Gerald C., Vaysse P.J., Forray C. Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat. Med. 2002, 8:825-830.
3. Chaki S., Funakoshi T., Hirota-Okuno S., Nishiguchi M., Shimazaki T., Iijima M., Grottick A.J., Kanuma K., Omodera K., Sekiguchi Y., Okuyama S., Tran T.A., Semple G., Thomsen W. Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists. J. Pharmacol. Exp. Ther. 2005, 313:831-839.
4. Chung S., Hopf F.W., Nagasaki H., Li C.Y., Belluzzi J.D., Bonci A., Civelli O. The melanin-concentrating hormone system modulates cocaine reward. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:6772-6777.
5. Chung S., Parks G.S., Lee C., Civelli O. Recent updates on the melanin-concentrating hormone (MCH) and its receptor system: lessons from MCH1R antagonists. J. Mol. Neurosci. 2011, 43:115-121.
6. Clinton S.M., Vazquez D.M., Kabbaj M., Kabbaj M.H., Watson S.J., Akil H. Individual differences in novelty-seeking and emotional reactivity correlate with variation in maternal behavior. Horm. Behav. 2007, 51:655-664.
7. Clinton S., Miller S., Watson S.J., Akil H. Prenatal stress does not alter innate novelty-seeking behavioral traits, but differentially affects individual differences in neuroendocrine stress responsivity. Psychoneuroendocrinology 2008, 33:162-177.
8. Clinton S.M., Bedrosain T.A., Abraham A.D., Watson S.J., Akil H. Neural and environmental factors implicating maternal behavior differences in high- versus low-novelty-seeking rats. Horm. Behav. 2010, 54:463-473.
9. David D.J., Klemenhagen K.C., Holick K.A., Saxe M.D., Mendez I., Santarelli L., Craig D.A., Zhong H., Swanson C.J., Hegde L.G., Ping X.I., Dong D., Marzabadi M.R., Gerald C.P., Hen R. Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphen yl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. J. Pharmacol. Exp. Ther. 2007, 321:237-248.
10. García-Fuster M.J., Clinton S.M., Watson S.J., Akil H. Effect of cocaine on Fas-associated protein with death domain in the rat brain: individual differences in a model of differential vulnerability to drug abuse. Neuropsychopharmacology 2009, 34:1123-1134.
11. Gehlert D.R., Rasmussen K., Shaw J., Li X., Ardayflo P., Craft L., Coskun T., Zhang H.Y., Chen Y., Witkin J.M. Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression. J. Pharmacol. Exp. Ther. 2009, 329:429-438.
12. Georgescu D., Sears R.M., Hommel J.D., Barrot M., Bolaños C.A., Marsh D.J., Bednarek M.A., Bibb J.A., Maratos-Flier E., Nestler E.J., DiLeone R.J. The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J. Neurosci. 2005, 25:2933-2940.
13. Jama A., Cecchi M., Calvo N., Watson S.J., Akil H. Inter-individual differences in novelty-seeking behavior in rats predict differential responses to desipramine in the forced swim test. Psychopharmacology 2008, 198:333-340.
14. Kabbaj M., Devine D.P., Savage V.R., Akil H. Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J. Neurosci. 2000, 20:6983-6988.
15. Kerman I.A., Bernard R., Rosenthal D., Beals J., Akil H., Watson S.J. Distinct populations of presympathetic-premotor neurons express orexin or melanin-concentrating hormone in the rat lateral hypothalamus. J. Comp. Neurol. 2007, 505:586-601.
16. Lagos P., Urbanavicius J., Scorza M.C., Miraballes R., Torterolo P. Depressive-like profile induced by MCH microinjections into the dorsal raphe nucleus evaluated in the forced swim test. Behav. Brain Res. 2011, 218:259-266.
17. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat. Neurosci. 2010, 13:1161-1169.
18. Pachoud B., Adamantidis A., Ravassard P., Luppi P.H., Grisar T., Lakaye B., Salin P.A. Major impairments of glutamatergic transmission and long-term synaptic plasticity in the hippocampus of mice lacking the melanin-concentrating hormone receptor-1. J. Neurophysiol. 2010, 104:1417-1425.
19. Perez J.A., Clinton S.M., Turner C.A., Watson S.J., Akil H. A new role for FGF2 as an endogenous inhibitor of anxiety. J. Neurosci. 2009, 29:6379-6638.
20. Roy M., David N.K., Danao J.V., Baribault H., Tian H., Giorgetti M. Genetic inactivation of melanin-concentrating hormone receptor subtype 1 (MCHR1) in mice exerts anxiolytic-like behavioral effects. Neuropsychopharmacology 2006, 31:112-120.
21. Roy M., David N., Cueva M., Giorgetti M. A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression. Biol. Psychiatry 2007, 61:174-180.
22. Saito Y., Cheng M., Leslie F.M., Civelli O. Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain. J. Comp. Neurol. 2001, 435:26-40.
23. Stead J.D., Clinton S., Neal C., Schneider J., Jama A., Miller S., Vazquez D.M., Watson S.J., Akil H. Selective breeding for divergence in novelty-seeking traits: heritability and enrichment in spontaneous anxiety-related behaviors. Behav. Genet. 2006, 36:697-712.
24. Stedenfeld K.A., Clinton S.M., Kerman I.A., Akil H., Watson S.J., Sved A.F. Novelty-seeking behavior predicts vulnerability in a rodent model of depression. Physiol. Behav. 2011, 103:210-216.
25. Turner C.A., Clinton S.M., Thompson R.C., Watson S.J., Akil H. Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:8021-8025.
26. Varas M., Perez M., Monzon M.E., de Barioglio S.R. Melanin-concentrating hormone, hippocampal nitric oxide levels and memory retention. Peptides 2002, 23:2213-2221.
27. Villalobos J., Ferssiwi A. The differential ascending projections from the anterior, central and posterior regions of the lateral hypothalamic area: an autoradiographic study. Neurosci. Lett. 1987, 81:89-94.